
Insulin Developer and Manufacturer
The United Laboratories(03933) Continued to perform well in the morning session, currently up 5.37%, trading at HK$8.83, hitting a new high since September 2020, with a turnover of HK$88.4752 million.
Novo Nordisk recently announced that the GLP-1 drug Ozempic has reached the pre-specified endpoint for early termination in a Phase III clinical trial aimed at preventing the progression of kidney damage in patients with Type 2 diabetes and chronic kidney disease. The stock price of Novo Nordisk, a U.S.-listed weight-loss drug concept stock, hit a record high yesterday.
Editor: Lu Yujun